JLP 2008
Alternative Names: JLP-2008Latest Information Update: 24 Jan 2024
At a glance
- Originator Jeil Pharmaceutical
- Class Antihyperglycaemics
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Diabetes mellitus
Most Recent Events
- 03 May 2022 Phase-I clinical trials in Diabetes mellitus (In volunteers) in South Korea (unspecified route) (NCT06165965)